Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody ; volume:50 ; number:5 ; day:13 ; month:1 ; year:2023 ; pages:1306-1317 ; date:4.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 5 (13.1.2023), 1306-1317, 4.2023
- Urheber
-
Stergiou, N.
Wuensche, T. E.
Schreurs, M.
Mes, I.
Verlaan, M.
Kooijman, E. J. M.
Windhorst, A. D.
Helboe, L.
Vergo, S.
Christensen, S.
Asuni, A. A.
Jensen, A.
Van Dongen, G. A. M. S.
Bang-Andersen, B.
Vugts, D. J.
Beaino, W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-023-06109-3
- URN
-
urn:nbn:de:101:1-2023080921015204573675
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stergiou, N.
- Wuensche, T. E.
- Schreurs, M.
- Mes, I.
- Verlaan, M.
- Kooijman, E. J. M.
- Windhorst, A. D.
- Helboe, L.
- Vergo, S.
- Christensen, S.
- Asuni, A. A.
- Jensen, A.
- Van Dongen, G. A. M. S.
- Bang-Andersen, B.
- Vugts, D. J.
- Beaino, W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Comparison of Monoclonal and Polyclonal Enzyme Immuno Assays for Carcinoembryonic Antigen
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Bispecific antibodies
Bispecific antibodies
Immuno-oncology
Immuno-Oncology
ImmunoMedicine
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Comparison of Monoclonal and Polyclonal Enzyme Immuno Assays for Carcinoembryonic Antigen
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Bispecific antibodies
Bispecific antibodies
Immuno-oncology
Immuno-Oncology
ImmunoMedicine
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Comparison of Monoclonal and Polyclonal Enzyme Immuno Assays for Carcinoembryonic Antigen
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Bispecific antibodies
Bispecific antibodies
Immuno-oncology
Immuno-Oncology
ImmunoMedicine